Patent · US Active

Methods and compositions for cytomegalovirus IL-10 protein

US9321813B2 · kind B2 · utility

0Cited by
0References
5Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMar 27, 2012
Grant dateApr 26, 2016
Priority date
Expiry dateMar 27, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2710/16162
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides methods and compositions for treating and/or preventing a cytomegalovirus infection in a subject, comprising administering to the subject an effective amount of a cytomegalovirus interleukin-10 (IL-10) protein modified to have reduced functional activity while retaining immunogenicity. The present invention further provides nucleic acid molecules encoding a cytomegalovirus IL-10 protein or fragment thereof of this invention as well as vectors comprising such nucleic acids. Also provided herein are neutralizing antibodies that specifically bind cmvIL-10.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.